Stock Taper
LENSAR, Inc. develops and markets a femtosecond laser system for cataract treatment and astigmatism management, offering advanced imaging, planning, and precision technologies to improve surgical outcomes.

The ALLY Adaptive Cataract Treatment System by LENSAR is an advanced femtosecond laser platform that enhances precision and efficiency in cataract surgery through integrated imaging and robotic technology in a compact design.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Product | $11.37M | $12.73M ▲ | $10.08M ▼ | $13.04M ▲ |
![]() | Service | $1.39M | $1.6M ▲ | $1.67M ▲ | $1.68M ▲ |
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | UNITED STATES | $8.67M | $11.19M ▲ | $8.53M ▼ | $10.4M ▲ |
![]() | Europe | $2.31M | $1.46M ▼ | $1.88M ▲ | $2.31M ▲ |
![]() | Asia | — | — | $1.26M | $1.95M ▲ |
![]() | Asia Excluding South Korea | $1.55M | $1.52M ▼ | — | — |
![]() | KOREA REPUBLIC OF | $183K | $106K ▼ | — | — |
![]() | Other Geographical Region | $41K | $54K ▲ | $67K ▲ | $62K ▼ |
Overall rating: B+
| PEER | PRICE | |
|---|---|---|
AVR | $8.74 | COMPARE |
TLSI | $4.83 | COMPARE |
ANIK | $21.10 | COMPARE |
PROF | $6.85 | COMPARE |
CRBP | $10.91 | COMPARE |
MXCT | $1.22 | COMPARE |
OWLT | $4.99 | COMPARE |
CRDF | $0.94 | COMPARE |